جست‌وجوی استاد و پژوهشگر

Anna Zampetakiمشاهده پروفایل

مدرس ارشد

• Cardiovascular Biology
• Vascular Biology
• Regenerative Medicine
• +۴ مورد دیگر

Dr. Anna Zampetaki is a Senior Lecturer in Cardiovascular Biology at King's College London, affiliated with the School of Cardiovascular and Metabolic Medicine & Sciences. She leads research on molecular mechanisms of vascular injury/repair, focusing on metabolic pathways and regenerative medicine. Her work integrates organoid technologies, iPS cells, and gene editing to uncover therapeutic targets for vascular diseases. Education details are not explicitly listed, but her career trajectory includes significant contributions to microRNA biology and vascular regeneration. Her research interests span vascular biology, metabolic influences on vascular health, and translational applications of organoid models. Key research trends include the role of microRNAs (e.g., miR-126, miR-199a-3p) in vascular dysfunction, the application of blood vessel organoids to study diabetic vasculopathy, and leveraging CRISPR/Cas9 for understanding clustered miRNA regulation. Collaborations involve teams at King's College and international institutions. No scientific awards are explicitly mentioned in the text. Teaching responsibilities include courses on vascular physiology, experimental cardiovascular research, and biomedical translational science. She oversees laboratory rotations and project supervision in molecular science and pharmacology. The Zampetaki Lab actively develops vascular organoid models to study metabolic influences on microvascular integrity and diabetes-related vascular complications. Current projects include investigating CTGF's role in microvascular maintenance and exploring regenerative potential in cardiac tissues.

• Pathology
• Oncology
• Molecular Diagnostics
• +۳ مورد دیگر

Prof. Aptullah HAHOLU is a Professor at the Department of Medical Pathology, Faculty of Medicine, Üsküdar University. Previously, he served as an Associate Professor at GATA Haydarpaşa Training Hospital (2009-2021) and retired from the Turkish military in 2017. His academic journey includes a medical degree from Gülhane Military Medical Academy (1991) and a pathology residency at Georgetown University (1999-2000). He has held administrative roles such as Vice Dean and Course Coordinator at Üsküdar University. His research focuses on oncology, molecular pathology, and experimental therapeutics, with over 89 publications and an h-index of 19. He teaches medical terminology and pathology courses, and his work spans miRNA biomarker development, vaccine side effects, and surgical pathology challenges. Education: MD from GATA (1991), pathology specialization (1997), and academic promotions to Associate Professor (2009) and Professor (2021). His research highlights include studies on Helicobacter pylori in carcinomas, ozone therapy efficacy, and genetic mutations in melanomas. He has contributed to clinical guidelines on cardiovascular treatments and authored peer-reviewed articles on rare pathologies like renal metastases from pancreatic adenocarcinoma. Administrative Roles: Current Vice Dean at Üsküdar University Faculty of Medicine, coordinating medical committees and curricula. His teaching portfolio includes undergraduate medical courses in pathology and terminology. Grants and projects include experimental studies on vagus nerve stimulation in arthritis (2026).

Giordano Lippiمشاهده پروفایل

دانشیار

• Neuroscience
• Non-coding RNAs
• Neurodevelopmental Disorders
• +۴ مورد دیگر

Giordano Lippi is an Associate Professor in the Department of Neuroscience at The Scripps Research Institute (TSRI), located at the Dorris Neuroscience Center in La Jolla, California. He is also affiliated with UC San Diego's Neurosciences Graduate Program. His research focuses on understanding how non-coding RNAs, particularly microRNAs (miRNAs), regulate neuronal development and function, with implications for neurodevelopmental disorders like autism, schizophrenia, and epilepsy. Dr. Lippi's work combines molecular biology and circuit neuroscience to identify gene programs critical for stable neural network formation. His lab has developed cutting-edge tools, including a peptide for reversible miRNA inhibition and mouse models to map miRNA-target interactions in rare neuronal subtypes. These innovations enable precise investigation of miRNA roles in neuronal identity, synaptic plasticity, and network stability. Key Research Themes: miRNA regulation of neuronal diversity, miRNA roles in critical developmental windows, evolution of miRNA functions in primates. Awards: Whitehall Foundation Award (2018), MRC Career Development Fellowship (2006), EMBO Short-Term Fellowship (2005). Lab Affiliations: Dorris Neuroscience Center (TSRI), UCSD Neurosciences Graduate Program. His recent publications highlight discoveries such as miRNA-218's role in hippocampal network assembly and miRNA necessity for Purkinje cell identity. Ongoing projects explore evolutionary functions of primate-specific miRNAs and their impact on cognitive abilities.

Alison H. Goodallمشاهده پروفایل

استاد

• Thrombosis
• Cardiovascular Disease
• Haematology
• +۷ مورد دیگر

Professor Alison H. Goodall is a Professor of Thrombosis and Haemostasis at the University of Leicester's Department of Cardiovascular Sciences. She holds a PhD in Biochemistry from London University and has been a leading figure in vascular biology research since 1997. Her work focuses on thrombosis regulation, atherosclerosis, and cross-talk between vascular cells. She co-founded Haemostatix Ltd, a University spin-out company developing anticoagulant therapies, sold in 2016 after successful clinical trials. Her research explores platelet-monocyte interactions in cardiovascular disease, cancer, and dementia. Key areas include procoagulant platelet signaling, microparticle biology, and genetic factors like TRIB1/3 in atherogenesis. Her studies bridge clinical and basic science, with contributions to diagnostic markers (e.g., exhaled breath metabolites) and anticoagulant drug mechanisms (e.g., heparin-aspirin interactions). Publications highlight platelet activation in acute kidney injury post-cardiac surgery, mathematical coagulation modeling, and molecular pathways in aging macrophages. She has also investigated thrombotic risks in cancer patients and lipid mediator profiles from platelet activation. Despite her extensive contributions, no specific scientific awards are listed. Her work integrates translational research across academia and industry, with ongoing studies on tumor-associated macrophages, miRNA-driven pathways, and proteomic stratification of myocardial infarction. Collaborations span cardiology, oncology, and immunology, reflecting her interdisciplinary approach to vascular disease mechanisms.

• Extracellular Vesicle Research
• Gestational Diabetes Mellitus
• Placental Biology
• +۳ مورد دیگر

Dr. Nanthini Jayabalan is a Postdoctoral Research Fellow in the School of Mech., Medical & Process Engineering at Queensland University of Technology (QUT). Her research focuses on extracellular vesicles, placental biology, and gestational diabetes mellitus (GDM). She has contributed to understanding the role of adipose tissue-derived exosomes in placental metabolism and fetal growth regulation. Her work also explores miRNA and protein biomarkers in maternal-fetal communication and their implications in GDM and neurodegenerative diseases like Parkinson’s. She is affiliated with QUT’s Centre for Microbiome Research. Her qualifications include a PhD from the University of Queensland and an M.Sc. in Cellular and Molecular Neuroscience. Key research areas include exosome-mediated cell communication, metabolic regulation in pregnancy, and microbiome interactions in disease. Her publications span interdisciplinary studies in placental biology, diabetes, and neuropharmacology, with a focus on translational applications.

Alika K. Maunakeaمشاهده پروفایل

استاد

• Epigenetics
• Gene-Environment Interactions
• Health Disparities
• +۶ مورد دیگر

Alika K. Maunakea, PhD, is a Professor in the Department of Anatomy, Biochemistry & Physiology at the John A. Burns School of Medicine, University of Hawaii. A Native Hawaiian born in Waiʻanae, Hawaiʻi, he earned his B.Sc. in Biology from Creighton University (2001) and PhD in Biomedical Sciences from University of California, San Francisco (2008), followed by postdoctoral training at the National Institutes of Health (2012). His research focuses on epigenetics, particularly DNA methylation and histone modifications, to elucidate gene-environment interactions in health disparities such as diabetes and neurodevelopmental conditions among Native Hawaiian and Pacific Islander (NHPI) populations. Education: Creighton University (B.Sc. Biology), University of California, San Francisco (PhD Biomedical Sciences) Dr. Maunakea integrates multi-omic approaches (epigenomics, microbiome, transcriptomics) with community-engaged research to identify early disease biomarkers and address NHPI health inequities. He directs the Epigenomics Core Facility of Hawaii and the NIH COBRE-funded Consortium of Research Advancement Facilities and Training (CRAFT), and leads studies like the Hawaiʻi Social Epigenomics of Early Diabetes (HI-SEED.org) and Maui Wildfire Exposure Study (www.mauiwes.info). His work on the NIH-funded RADxUP initiative established Hawaii's first CLIA-certified molecular diagnostics lab at a Federally Qualified Health Center serving NHPI communities. His publications span epigenetic mechanisms in autism, diabetes, HIV-related insulin resistance, and SARS-CoV-2 sequelae, with methodology innovations in DNA methylation analysis and next-generation sequencing. He mentors underrepresented minority students in multidisciplinary research careers and collaborates with clinical, behavioral, and economic researchers. Key grants include NIH R01 for HI-SEED.org and multiple NIH grants supporting his career. Current affiliations include graduate faculty roles in the Departments of Molecular Biosciences and Bioengineering, Public Health Studies, Developmental and Reproductive Biology, and Cell and Molecular Biology, with leadership in neuroscience and cancer biology programs.

• Immunology
• Cancer Biology
• Regulatory T-Cell Biology
• +۴ مورد دیگر

Dr. Cheryl Brown is a Grant-Funded Researcher (B) at the University of Adelaide's School of Biomedicine, within the Faculty of Health and Medical Sciences. She holds appointments at the Women's and Children's Hospital and the Robinson Research Institute. Her primary research focuses on regulatory T-cell biology, cancer mechanisms, and translational regulation, with a particular interest in epigenetic and genomic approaches to understanding immune function and disease. Education PhD in Biomedicine, University of Adelaide (1992–1996) MSc in General and Medical Microbiology, University College London (1990–1991) Research Interests Dr. Brown's work spans immunology, cancer biology, and molecular mechanisms. Key areas include T-cell plasticity in autoimmune diseases, FOXP3 regulation in regulatory T cells, epigenetic control of gene expression, and the impact of microbiota on health. Her lab employs cutting-edge techniques such as chromatin conformation capture, single-cell profiling, and microRNA analysis to dissect these processes. Publications Her recent work highlights contributions to understanding regulatory T cell dynamics in type 1 diabetes, breast cancer progression mediated by microRNAs, and gut microbiota analysis methodologies. These studies underscore translational insights into immune disorders and cancer biology. Awards & Grants No specific awards are listed, but her grant-funded position indicates sustained research support. She is eligible to supervise Master's and PhD students, focusing on mentorship in immunology and molecular biology. Labs & Collaborations Her affiliations with the Women's and Children's Hospital and Robinson Research Institute enable multidisciplinary collaborations in clinical and basic science research. Previous postdoctoral work at the Fred Hutchinson Cancer Research Center (USA) and University of Washington further enriched her expertise in translational cancer research and apoptosis pathways.

Zhenyu Xuanمشاهده پروفایل

دانشیار

• Cancer Genomics
• Systems Biology
• Computational Biology
• +۳ مورد دیگر

Zhenyu Xuan is an Associate Professor in the Department of Biological Sciences at the University of Texas at Dallas (UTD), part of the School of Natural Sciences and Mathematics. His research focuses on developing computational methods to analyze cancer genomics data and understand carcinogenesis mechanisms. He holds a Ph.D. in Bioinformatics from the Chinese Academy of Sciences (2000) and a B.S. in Theoretical Physics from Nanjing University (1995). Professional preparation includes postdoctoral fellowships at Cold Spring Harbor Laboratory (2000–2010) before joining UTD in 2010. Research interests span systems biology approaches to high-throughput data, including NGS and microarray analysis, with applications in cancer genomics, epigenomics, and infectious disease pathways. Recent work explores mechanisms linking mitochondrial dysfunction to Alzheimer’s disease, PRC2 heterogeneity in medulloblastoma, and computational drug-target prediction. Awards include the Di Ao Award (2000) and Second Yi Li Da Prize (1996) from the Chinese Academy of Sciences. His lab investigates transcriptional regulation, viral pathogenesis, and cellular signaling networks. He has contributed to projects such as CoreBoost_HM promoter prediction and TargetLink miRNA target identification. Active in collaborative research, he has published over 100 peer-reviewed articles spanning computational biology, genomics, and systems biology.

• Neuroscience
• Genomics
• Proteomics
• +۶ مورد دیگر

Enrico Domenici is an Associate Professor at the Department of Cellular, Computational, and Integrative Biology (CIBIO), University of Trento. He holds a PhD in Molecular Sciences/Chemistry from Scuola Normale Superiore, University of Pisa (1986–1990), and a Laurea in Biological Sciences from the University of Pisa (1980–1984). His research focuses on genomic and proteomic biomarkers in neuroscience, particularly schizophrenia, autism, and neurodegenerative disorders. He has led projects in drug discovery, functional genomics, and translational medicine, including roles at Roche and GSK. He coordinates international consortia such as the FP7 IN-SENS and CommonMind Consortium. His work integrates high-throughput genomic and proteomic data to identify therapeutic targets and biomarkers. Key collaborations include partnerships with institutions like the Max Planck Institute of Psychiatry and the University of Helsinki, focusing on depression, stem cell research, and biomarker discovery. He has secured major grants, including the EU-funded GENDEP project (€7.5M) and the IN-SENS initiative (€3.9M). His research spans preclinical to clinical stages, emphasizing systems biology approaches and multi-omics integration. He advises on psychiatric genetics and serves on editorial boards for journals like Molecular Psychiatry and Neuropsychopharmacology . His scientific contributions include identifying biomarkers for depression and schizophrenia, analyzing genetic risk variants in autism, and modeling disease mechanisms in neurodegenerative disorders. He has supervised numerous students and fosters translational research through academia-industry partnerships. Current efforts emphasize leveraging omics data for precision medicine in neuropsychiatric disorders.

• Breast Cancer
• Molecular Biology
• Metastasis
• +۱۵ مورد دیگر

Erik Knutsen is an Associate Professor at the Institute of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway. He holds a PhD in Medical Biology and a Master’s in Molecular Biotechnology. He currently serves as the Study Program Leader for the Bachelor program in Biomedicine and teaches cellular biology at undergraduate and graduate levels. His research is centered on breast cancer metastasis, focusing on molecular mechanisms such as epithelial-mesenchymal transition (EMT), tumor microenvironment, non-coding RNAs, and single-cell sequencing. He leads a major project using single-cell RNA-seq to subclassify breast cancer cells in lymph nodes for improved diagnosis and personalized treatment. His goal is to prevent overtreatment and understand tumor dormancy and recurrence. Erik’s recent publications span high-impact journals like Nature , PNAS , and Journal of Clinical Investigation , with research themes in bioinformatics, CRISPR/Cas, serglycin, miRNA regulation, and liquid biopsies. His work often involves large-scale computational analysis and collaboration with clinicians, bioinformaticians, and molecular biologists. Scientific Awards: No specific awards listed in the provided text. Erik is currently supervising two PhD students and one master student as main supervisor, and one PhD student as co-supervisor. He has previously supervised multiple master’s, bachelor’s, and Erasmus+ trainee students. His research is supported by strong national and international collaborations, including work with George A. Calin at MD Anderson. He has led projects on functional RNA profiling, miRNA variations, and transcriptome analysis in cancer. He is based in Tromsø and actively contributes to both research and education in molecular oncology.

Mostafa Zamanianمشاهده پروفایل

دانشیار

• Parasitology
• Helminth Biology
• Neglected Tropical Diseases
• +۱۳ مورد دیگر

Mostafa Zamanian is an Associate Professor in the Department of Pathobiological Sciences at the University of Wisconsin–Madison, School of Veterinary Medicine. He leads an active research laboratory focused on parasitic helminths, particularly filarial and neglected tropical diseases, combining molecular, genomic, and computational approaches. He is affiliated with multiple graduate training programs, including Comparative Biomedical Sciences (CBMS), Microbiology Doctoral Training Program (MDTP), Cell and Molecular Pathology (CMP), Molecular and Cell Pharmacology (MCP), and Quantitative Biology (QBio). He also serves on NIH T32 training grants in Parasitology and Vector Biology (PVB) and Genomic Sciences Training Program (GSTP). His research aims to understand the biology of neglected parasitic diseases and develop novel strategies to disrupt host-parasite interactions. Key areas include parasite secretory functions , exosome biology , chemosensation , drug resistance mechanisms , and new drug target identification . The lab employs cutting-edge techniques such as spatial transcriptomics, single-cell analysis, long-read RNA sequencing, and image-based phenotyping. The recent publications reflect a strong trend toward integrating genomics and systems biology to understand parasite behavior and identify vulnerabilities. Work spans from field studies in the Colombian Amazon to high-throughput drug screening and computational modeling. A major focus is on Mansonella , Brugia , and Schistosoma species, with applications in diagnostics, epidemiology, and therapeutic development. Scientific awards and recognitions include: NIH F32 Fellowship Ford Foundation Predoctoral Fellowship (Honorable Mention) NSF GRFP Honorable Mention 1st Place Poster Prize at BSP/ISP Joint Meeting GHI Visiting Scholar Award Multiple presentation awards at national meetings Dr. Zamanian is actively involved in mentoring, advising graduate and undergraduate students, and securing competitive grants. His lab has received funding from: NIH/NIAID R01 (Parasite secretory function) NIH/NIAID K22 Phase II Award Parasitology and Vector Biology T32 Training Grant (PVB) Genomic Sciences Training Program (GSTP) Global Health Institute (GHI) Grant National Center for Veterinary Parasitology (NCVP) / AHS He trains students through multiple interdisciplinary programs and encourages fellowship applications from postdoctoral researchers. The Zamanian Lab is a dynamic team of postdocs, PhD students, and undergraduates working on diverse aspects of helminth biology. Current members include Kendra Dahmer, Nic Wheeler, Katie Ryan, Clair Henthorn, and postdoc Sebastián Díaz based in Medellín, Colombia. The lab fosters international collaboration and field-based research, particularly in endemic regions of South America.

• Anticancer drug development
• Virology
• Immunology
• +۵ مورد دیگر

Barbara Zdzisińska is a Professor at the Department of Virology and Immunology, Institute of Biological Sciences, Faculty of Biology and Biotechnology, Maria Curie-Skłodowska University. Her research focuses on molecular mechanisms of anticancer agents and bone formation stimulators. Role: Professor Contact: barbara.zdzisinska@mail.umcs.pl Office Hours: Mondays & Fridays 12:00-13:00 Research Interests Dr. Zdzisińska investigates: Molecular mechanisms of synthetic and natural anticancer compounds Bone formation stimulators Cytokine and metalloproteinase interactions in diseases Apoptosis induction in cancer cells Signaling pathways in tumor progression Comparative studies in human and veterinary oncology Recent Research Trends Her recent publications highlight: Development of novel antiproliferative agents (thiazoles, phosphonates) Mechanistic studies of natural compounds (apigenin, xanthohumol) Focus on JNK, ERK, and caspase-dependent pathways Applications in osteosarcoma, lung cancer, and myeloma Use of molecular docking and DFT calculations VEGF and microRNA biomarkers in veterinary models Academic Contributions She has contributed to: Understanding TGF-β and NEP interactions in colon cancer Development of Protocols for cell culture (Praktikum z hodowli komórek i tkanek, 2019) Immunology education (Immunologia człowieka, 2013)

Paul McVeighمشاهده پروفایل

مدرس ارشد

• Parasitology
• Molecular Parasitology
• RNA Interference
• +۴ مورد دیگر

Paul McVeigh is a Senior Lecturer at the School of Biological Sciences, Queen's University Belfast, and an active member of the Institute for Global Food Security. Based in Room 01.076 of the Biological Sciences building, he maintains a robust research program focused on helminth parasites and is currently accepting PhD students. His work bridges molecular biology and parasitology with strong institutional support from the university. His research interests center on molecular mechanisms of parasite biology, particularly: RNA interference dynamics in juvenile liver flukes Non-coding RNA profiles (microRNAs, lncRNAs) in Fasciola hepatica and Strongyloides Neuropeptide signaling systems and GPCR identification Stem cell biology in platyhelminths Drug target discovery for trematodes and nematodes Extracellular RNA as diagnostic biomarkers Molecular surveillance of parasite DNA on pasture Analysis of his 82 research outputs reveals a sustained emphasis on RNA-based approaches to parasite control since 2020, with increasing focus on stem cells and neuropeptide targets. The 2024-2025 publications demonstrate translational applications in disease risk assessment and growth regulation, while his 2023 review on Strongyloides questions outlines critical future directions for diagnostics and therapeutics. No scientific awards were documented in the provided materials. McVeigh actively supervises PhD students (noted in "Supervised Work (2)") and serves as both internal and external examiner, including chairing vivas for Dr. Abdullah Albaqami (2024) and examining Dr. Rebecca Armstrong at QUB (2023). He hosts international collaborators like Dr. Vicky L. Hunt (2024) and serves as external examiner for institutions including the University of Calgary. His editorial activities and keynote talks (e.g., "Can small RNAs help address the big issues in helminth parasite control?" in 2023) highlight leadership in the field, though specific grant funding is not detailed in the text. As a core researcher in Queen's Institute for Global Food Security, McVeigh leads molecular parasitology work within the School of Biological Sciences. His lab employs transcriptomics, RNAi, and in silico methods to study Fasciola hepatica and Strongyloides, with datasets publicly available (e.g., for long non-coding RNA discovery). International collaborations span Canada, Australia, and Europe, targeting parasite control through mechanistic biology.

Konstantina Stathopoulouمشاهده پروفایل

پژوهشگر

• Cardiovascular Research
• Redox Biology
• Molecular Pharmacology
• +۲ مورد دیگر

Dr. Konstantina Stathopoulou is a researcher at the Institute of Experimental Pharmacology and Toxicology , Universitätsklinikum Hamburg-Eppendorf (UKE). She specializes in cardiovascular molecular mechanisms with focus areas including redox signaling, kinase/phosphatase regulation, mitochondrial dynamics in cardiomyocytes, and stem cell-based disease modeling. Her work integrates experimental pharmacology with cardiac pathophysiology. Research Focus: Her investigations center on oxidative stress responses in cardiac cells, protein interaction networks regulating contractility, and metabolic adaptations in cardiomyopathy. Key methodologies include hiPSC-derived cardiomyocyte models, kinase activity profiling, and redox proteomics to decipher molecular drivers of heart failure. Publication Trends: Recent works (2020-2024) emphasize mitochondrial physiology in stem cells, ferroptosis mechanisms in metabolic cardiomyopathy, and high-resolution analysis of cardiac signaling pathways. Earlier studies (2012-2019) established foundations in HDAC regulation, extracellular matrix remodeling, and kinase inhibitor pharmacology.

• Pediatric Surgery
• Pathology
• Cancer Research
• +۳ مورد دیگر

Arnis Eņģelis is a Lecturer at the Department of Paediatric Surgery at Rīga Stradiņš University , affiliated with the Children's Clinical University Hospital Rīga . His academic and clinical work spans pediatric surgery, pathology, and cancer research. Education: PhD in Medicine (2013), Doctoral Degree in Medicine (2012), Residency in Pathology (2009), Physician's Diploma (2005). Research Interests: Focus on molecular pathology, immunohistochemistry, hereditary/sporadic cancer syndromes, gastric and breast cancer diagnostics, and rare pediatric tumors. His work bridges clinical practice with translational research, particularly in miRNA expression and tumor heterogeneity. Scientific Engagement: Active in Baltic and international pathology symposiums (e.g., European Congress of Pathology, Baltic Association of Surgeons). Key contributions include studies on medulloblastoma molecular profiles, inflammatory fibroid polyps, and Cowden syndrome management. Collaborations: Frequently collaborates with researchers like Ilze Štrumfa, Jana Gardovska, and others on multidisciplinary projects. Involved in population screening initiatives for hereditary cancers in Latvia.